Please provide your email address to receive an email when new articles are posted on . Researchers captured patient and caregiver expected anxiety and well-being with different epinephrine treatment ...
It's well known that stress can trigger hair loss. A new paper explores how this happens and how our response to stress can have long-term consequences for our scalps, research that may eventually ...
neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in adults and children aged 4 years and older who weigh 33 lbs. or greater. neffy is indicated for ...
An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...
The MarketWatch News Department was not involved in the creation of this content. Belhaven's Investigational New Drug (IND) Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ...
The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen) for anaphylaxis and other allergic reactions -- and I will be prescribing ...
Oct 1 (Reuters) - ARS Pharmaceuticals (SPRY.O), opens new tab has filed an antitrust lawsuit against AptarGroup (ATR.N), opens new tab, accusing the drug delivery device manufacturer of maintaining an ...
If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback